*  Dr. Mark Huising Discusses His Work in Delta Cells & Diabetes Research
Dr. Mark Huising talks about his work in delta cells & diabetes research, their impact on the body, and the importance of imparting an understanding.
*  AACE Releases New Comprehensive Diabetes Management Algorithm
For treatment of diabetes and prediabetes patients.... The American Association of Clinical Endocrinologists (AACE) announced the publication of its new comprehensive diabetes management algorithm created to guide primary care physicians, endocrinologists and other health care professionals in the treatment of
*  Editor's Note, DCMS #190
Can you remember where the phrase, 'Warning, Will Robinson, warning warning!' came from? This week we have a real warning list for you to pay attention to as the information from ISMP in our Disaster Averted looks at the High Alert Medications that can have very serious complications if given to the wrong
*  U300 Insulin Glargine Produces Lower Rates of Night Time Hypoglycemia
A reduced risk of nocturnal hypoglycemia is among the advantages.... An international team of researchers conducted a trial as part of the multinatio
*  Does Byetta Work for Type 1's?
GLP-1 agonist may prove beneficial to type 1 diabetes.... Kevan Herold, MD, of Yale University, and colleagues reported that the GLP-1 agonist exenatide
*  'Why Insulin Therapy Doesn't Work,' Transcript: Israel Hodish, MD,...
Dr. Israel Hodish looks at the provocative topic, 'Why insulin therapy doesn't work & what we can do about it,' based on his research as an endocrinologist.
*  Issue #918 - Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals.
As 2017 draws to a close, every news outlet looks back to see what things made a real difference. We have our most popular articles for each month of the year. Steve and I can also look back over the past seventeen and a half years and see what we have accomplished.. For those of you who don't know it, we were two pharmacists who pestered every drug company, meter company and diabetes company to let us into the diabetes world.. We started this newsletter for a few pharmacists with no expectations of greatness. However because of you our readers, our fantastic interns, our well known Advisory Board members and the hardworking support staff that makes our jobs easy, we have grown into one of the largest and longest running healthcare e-zines available today.. Thanks for all your support and we look forward to serving you well into the future.. *****************************. We can make a difference!. *****************************. Dave Joffe. Editor-in-chief ...
*  Devices - Diabetes In Control
Smart Pill Bottle AdhereTech has created patented cloud-connected pill bottles that improve medication adherence. These bottles measure the exact number of pills or liquid in the bottle in real-time, wirelessly send this data into the cloud, and remind patients to take their medication via phone call or text. The devices …. Read More » ...
*  Diabetes and Pregnancy Testing at First Visit
New recommendations for testing and diagnosing diabetes among pregnant women.... Currently, recommendations for testing and diagnosing diabetes in women wh
*  AADE Survey Reveals Profile of Diabetes Educators
For the first survey of its kind for diabetes educators, they found that the average diabetes educator has a median salary of $64,900 per year, has a bachelor's degree and is 51 years of age, according to the 2008 Salary Survey released during the AADE's Annual Meeting in Atlanta. Diabetes education is a
*  Exclusive Interviews - Diabetes In Control
In part 5, the conclusion, of this Exclusive Interview, Dr. Linda Siminerio talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about care for the prediabetes patient and the importance of doctors conveying the severity of the situation.. Read More » ...
*  Lifestyle Changes during Prediabetes Can Reduce Mortality
Not only may an intensive program of diet, exercise, or both delay progression from prediabetes to diabetes, but among women, it may also lower CVD and all
*  Pharmacotherapy Options in the Treatment of Feline and Canine Diabetes
Janine Manning, Pharm.D. Candidate 2011 Lake Erie College of Osteopathic Medicine, School of Pharmacy As healthcare professionals, we have seen the increase in the occurrence of diabetes mellitus detected over the past decade in the human population. This has lead to treatment advances to help reduce diabetic
*  Physician
Central Intelligence Agency Location : Washington DC US Board certification in a primary care specialty--Family Medicine, Internal Medicine, Pediatrics, Pr
*  Insulin for Life Answering Calls for Help
Insulin for Life was able to get a private group to fly supplies from Gainesville, FL to Wharton, Texas, within 13 hours after receiving the call for help.
*  Editor's Note, DCMS #256
While researching some information for a CE I was preparing, I found out that approximately 74% of patients with diabetes have mild to severe hypertension.
*  Jan. 3, 2018
Now that we are in the new year our patients will have every good intention on changing everything to make this their best and healthiest year ever. They
*  New Insight on Levothyroxine Hypothyroidism Monotherapy
Data suggests chemical composition of levothyroxine monotherapy does not normalize serum T3 concentrations or universally restore clinical euthyroidism.
*  Richard Pratley on Anticipated Visit to the ADA Convention
In part 5, the conclusion of this Exclusive Interview, Richard Pratley talks with Diabetes in Control Publisher Steve Freed during the AACE meeting in Austin, Texas about his anticipated visit to the ADA convention.
*  High Blood Sugar Linked To Aging And Disease
Advanced glycation end products And Antioxidants Is it possible that by eating too many metabolically active dense carbohydrates, you are much more likely
*  ADA: Linagliptin Has Similar Efficacy to Glimepiride but Improved Cardiovascular Safety over 2 Years in Patients with Type 2...
Type 2 diabetes mellitus (T2DM) often requires combination therapy to maintain glycemic control. Adding a sulfonylurea to metformin therapy improves glycemic control, but can cause hypoglycemia and weight gain. This 2-yr double-blind trial investigated the long-term efficacy and safety of adding linagliptin or
*  Leveraging Weight Loss in the Treatment of Type 2 Diabetes 2012 Part 1 of 4
In this week's set of Homerun Slides, we begin a four part series on how weight gain affects the overall health of our overweight and obese type 2
*  Richard Pratley on Overweight and Obesity Among Patients with Type 1 Diabetes.
In part 1 of this Exclusive Interview, Richard Pratley talks with Diabetes in Control Publisher Steve Freed during the AACE meeting in Austin, Texas about his work with diabetes patients and the growing epidemic of overweight and obesity among patients with type 1 diabetes.
*  Production Assistant, Diabetes In Control, Author at Diabetes In Control. A free weekly diabetes newsletter for Medical...
It was a challenge to develop a computer model that could account for plasma dynamics in a compact but accurate package. The model was the simplest representation we could devise, which was based upon known physiology, and which could accurately describe moment-by-moment plasma dynamics. The model continues to thrive in that it continues to be the basis for a large number of clinical investigations (∼50 per year) as well as a robust literature related to its mathematical and computer characteristics Read More » ...
*  Outcomes of Self-monitoring of Blood Glucose in Type 2 Diabetes
Effect of frequent, self-monitoring of blood glucose may not be significant.... In this randomized controlled trial, researchers assessed whether